Study of TFX06 in Women With Advanced Breast Cancer.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: ER+, HER2- Advanced Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: TFX06 tablet
Sponsor: Shenzhen Yangli Pharmaceutical Technology Co., Ltd